Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sharon Tzadok"'
Autor:
Lisa Argnani, Rodrigo J Ruiz-Delgado, Pia Raanani, Xuebin Dong, Hongyu Zhao, Sergio Parco, Germano Bruno, Tienan Zhu, Huacong Cai, Francesco Malaspina, Rajul Shah, Jess F. Peterson, Cinzia Pellegrini, Ran Zhang, Monica Martinelli, Beatrice Casadei, Li Xu, Ping Chen, Yi-Xuan Li, Ofir Wolach, Hongming Zhu, Daqi Li, Daniel Kobrinski, Anna Gurevich-Shapiro, Aida Inbal, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles, Roberto Simeone, Juan Carlos Olivares-Gazca, Linping Gu, Jia-Feng Chen, Natalia Maximova, Xiang-Yu Meng, Xiaoyang Li, Guillermo Ruiz-Reyes, Manuel Priesca-Marin, Michal Bar-Natan, David Blumenkron-Marroquin, Daobin Zhou, Ana Karen Nuñez-Cortes, Satz Mengensatzproduktion, Sérgio Paulo Bydlowski, Iván Murrieta-Álvarez, Jiong Hu, Gina Cervi, Roberta Giacomello, Pier Luigi Zinzani, Jianhua Shao, Jian Li, Wei Zhang, Debora Levy, Luciana Morganti Ferreira Maselli, Andrés A. León-Peña, Cadiele Oliana Reichert, Yahveth Cantero-Fortiz, Ling-Fei Xiao, Gabriella Zito, Junmin Li, Stefania Luppi, Zi-Hang Zeng, Alejandro Ruiz-Argüelles, Miao Chen, Alina Rosenberg, Bing Han, Minghui Duan, Joel da Cunha, Yongjian Yang, Celso Spada, Manuel A Ruiz-Delgado, Yunxiang Zhang, Shujie Wang, Merari Starlight Torres-Priego, Xinxin Cao, Sharon Tzadok, Yubing Zhao, Yu Zheng, Jocelyn Vargas-Espinosa, Lu Zhang, Druckerei Stückle, Giuseppe Ricci, Emilio Medina-Ceballos, Xiaojing Lin, Mónica León-González
Publikováno v:
Acta Haematologica. 137:I-IV
Autor:
Dan Caspi, Ori Elkayam, Sharon Amir, Avital Angel-Korman, Ortal Segal, Aviram Gold, Sharon Tzadok, Noa Madar-Balakirski, Aharon Menachem, Uri Arad
Publikováno v:
Cytokine. 73:30-35
Galectin-3 is a β-galactoside-binding lectin that plays an important role in the modulation of immune responses. It has been shown to aggravate joint inflammation and destruction in experimental arthritis. We investigated the role of galectin-3 in T
Autor:
Pia Raanani, Anna Gurevich-Shapiro, Aida Inbal, Alina Rosenberg, Sharon Tzadok, Ofir Wolach, Michal Bar-Natan
Publikováno v:
Acta haematologica. 137(4)
Background: Refractoriness to platelet transfusion, prevalent among 15-20% of hemato-oncological patients, is associated with multitransfusions and inferior outcomes. We evaluated the effectiveness of extended slow-dose transfusion (ESDT) in increasi
Publikováno v:
Blood. 124:2888-2888
Background: Refractoriness to platelet transfusion is prevalent among 15-25% of hemato-oncology patients. Refractoriness has been linked to inferior clinical outcomes, including bleeding and mortality, as well as higher health care costs. Suggested e